Animal and their products used for treatment and prevention of disease practiced by traditional healers in Jimma Arjo district, East Wollega Zone, Western Ethiopia.

BACKGROUND: Ethiopia is one of the countries with richest fauna used for medicinal purpose. The Jimma Arjo community has knowledge and practice of utilizing this medicinal animal for treatment of human and animal ailments. OBJECTIVE: The objective of this research is to assess animals and their products used for treatment of human and animal ailment METHODS: A cross-sectional ethnozoological survey was conducted using a semi structured questionnaire among purposively selected traditional healers resided in Jimma Arjo district. The data collected was entered in Microsoft excel spread sheet and analysed using SPSS statistical software. Fidelity level (FL), use value and informant consensus factor was determined. RESULTS: A total of 33 animal species was found to be used for treating 40 human ailments and different livestock disease confirmed by 36 informants of different ages, sexes and educational backgrounds. The majority of animals (63.63%) were mammals followed by birds (15.15%). Most of the respondents were male, married and aged 55 years and above. Most of the healers learn ethnozoological practice from the father (36.11%) followed by mother (19.44%). The traditional practice is accepted by (72.22%) of the community where 61.11% of the healers are not willing to transfer their knowledge to other. For most of the healers, the reason to practice traditional healing was for treating one's own family or animals (41.67%). The FL was found 100% for honey from Apis mellifera and Trigona spp. for asthma, Cynopterus sphinx for viral skin disease and Crocuta crocuta for bad sprit treatment. In this study, honey from A. mellifera, Hystrix cristata and Sus scrofa domesticus were reported to cure different ailments. CONCLUSION: This study indicated wide use of medicinal animals and their products which could be used as an alternative and complementary medicine or a basis for in developing new drugs because the existing drugs especially antimicrobials are under threat due to the development of resistance by microbes.